Shaozhen Xie
- Oncology top 2%
- PARP inhibition in cancer therapy 4
- Immunology top 5%
- Immune Cell Function and Interaction 3
-
- Prostate Cancer Treatment and Research 4
- Advanced Breast Cancer Therapies 3
- Brain Metastases and Treatment 3
- Cancer Research top 5%
- Genetics top 5%
- Glioma Diagnosis and Treatment 4
-
- PI3K/AKT/mTOR signaling in cancer 6
-
- Nuclear Receptors and Signaling 5
Shaozhen Xie
29 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.5k
- Immunology 743
- Pulmonary and Respiratory Medicine 930
- Cancer Research 392
- Genetics 254
Countries citing papers authored by Shaozhen Xie
This map shows the geographic impact of Shaozhen Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaozhen Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaozhen Xie more than expected).
Fields of papers citing papers by Shaozhen Xie
This network shows the impact of papers produced by Shaozhen Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaozhen Xie. The network helps show where Shaozhen Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shaozhen Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 62 | |
| 3 | 2022 | 14 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 22 | |
| 6 | 2019 | 22 | |
| 7 | 2018 | 67 | |
| 8 | PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancerbreakdown → | 2018 | 395 |
| 9 | CDK4/6 inhibition triggers anti-tumour immunitybreakdown → | 2017 | 998 |
| 10 | CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancerbreakdown → | 2015 | 347 |
| 11 | 2012 | 125 | |
| 12 | 2011 | 16 | |
| 13 | 2009 | 4 | |
| 14 | 2008 | 22 | |
| 15 | 2005 | 109 | |
| 16 | 2004 | 36 | |
| 17 | 2003 | 39 | |
| 18 | 2003 | 139 | |
| 19 | 2003 | 51 | |
| 20 | 2003 | 16 |
About Shaozhen Xie
Shaozhen Xie is a scholar working on Oncology, Genetics and Cellular and Molecular Neuroscience, having authored 30 papers that have together received 3.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Nuclear Receptors and Signaling (5 papers), Glioma Diagnosis and Treatment (4 papers), Prostate Cancer Treatment and Research (4 papers), PARP inhibition in cancer therapy (4 papers), Advanced Breast Cancer Therapies (3 papers), Brain Metastases and Treatment (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (743 citations) and Pulmonary and Respiratory Medicine (930 citations). Shaozhen Xie has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Jean J. Zhao, Thomas M. Roberts, Chawnshang Chang, Eric P. Winer, Jing Ni, Jaclyn Sceneay, April C. Watt, Ian E. Krop, Matthew J. Ellis and Sandra S. McAllister. Their work appears in journals such as Journal of Biological Chemistry, Clinical Cancer Research, Scientific Reports, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.